Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: A Survey of Darvadstrocel in People With Crohn's Disease

View source ↗

Summary

Takeda is conducting a trial to evaluate darvadstrocel (Alofisel) in people with Crohn's disease, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alofisel (darvadstrocel)

Snippet

Sponsor: Takeda | Conditions: Crohn's Disease | Status: RECRUITING